Lycium Barbarum (Wolfberry) Reduces Secondary Degeneration and Oxidative Stress, and Inhibits JNK Pathway in Retina after Partial Optic Nerve Transection

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Li, Hongying ^a   Liang, Yuxiang ^a   Chiu, Kin ^a   Yuan, Qiuju ^a   Lin, Bin ^a   Chang, Raymond Chuen Chung ^a,b   So, Kwok Fai ^a,b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYCIUM BARBARUM EXTRACT; POLYSACCHARIDE; PROTEIN C JUN; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RETINA DEGENERATION; RETINA GANGLION CELL; RETINITIS;

ANIMALS; CELL SURVIVAL; FEMALE; INSULIN-LIKE GROWTH FACTOR I; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYCIUM; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OPTIC NERVE INJURIES; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RETINA; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84880441470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068881     Document Type: Article

References (45)

1. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, et al. (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36: 774-786.
2. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, et al. (2003) A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 44: 3388-3393.
3. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, et al. (2001) Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 42: 975-982.
4. Yoles E, Schwartz M, (1998) Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol 153: 1-7.
5. Prilloff S, Henrich-Noack P, Sabel BA, (2012) Recovery of axonal transport after partial optic nerve damage is associated with secondary retinal ganglion cell death in vivo. Invest Ophthalmol Vis Sci 53: 1460-1466.
6. Fitzgerald M, Bartlett CA, Evill L, Rodger J, Harvey AR, et al. (2009) Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Exp Neurol 216: 219-230.
7. Fitzgerald M, Bartlett CA, Harvey AR, Dunlop SA, (2010) Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study. J Neurotrauma 27: 439-452.
8. Fitzgerald M, Payne SC, Bartlett CA, Evill L, Harvey AR, et al. (2009) Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine. Invest Ophthalmol Vis Sci 50: 5456-5462.
9. Junlin L, Aicheng W (2002) Gou qi. Beijing: Bejing Science and Technology Press.
10. Ho YS, Yu MS, Yik SY, So KF, Yuen WH, et al. (2009) Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons. Cellular and molecular neurobiology 29: 1233-1244.
11. Yu MS, Ho YS, So KF, Yuen WH, Chang RCC, (2006) Cytoprotective effects of Lycium barbarum on cultured neurons against reducing stress on the endoplasmic reticulum. Neurosignals 15: 145-145.
12. Yu MS, Lai CS, Ho YS, Zee SY, So KF, et al. (2007) Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity. International journal of molecular medicine 20: 261-268.
13. Yu MS, Leung SK, Lai SW, Che CM, Zee SY, et al. (2005) Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 40: 716-727.
14. Chan HC, Chang RC, Koon-Ching Ip A, Chiu K, Yuen WH, et al. (2007) Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol 203: 269-273.
15. Mi XS, Feng Q, Lo AC, Chang RC, Lin B, et al. (2012) Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension. PLoS One 7: e45469.
16. Li SY, Yang D, Yeung CM, Yu WY, Chang RC, et al. (2011) Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PLoS One 6: e16380.
17. Fu QL, Hu B, Wu W, Pepinsky RB, Mi S, et al. (2008) Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest Ophthalmol Vis Sci 49: 975-985.
18. Chiu K, Lau WM, Yeung SC, Chang RC, So KF (2008) Retrograde labeling of retinal ganglion cells by application of fluoro-gold on the surface of superior colliculus. J Vis Exp.
19. Fu QL, Li X, Yip HK, Shao Z, Wu W, et al. (2009) Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma. Neuroscience 162: 375-382.
20. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, et al. (1995) In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21: 1465-1468.
21. Levkovitch-Verbin H, Spierer O, Vander S, Dardik R, (2011) Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline. Graefes Arch Clin Exp Ophthalmol 249: 849-857.
22. Fitzgerald M, Bartlett CA, Payne SC, Hart NS, Rodger J, et al. (2010) Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve. J Neurotrauma 27: 2107-2119.
23. Wells J, Kilburn MR, Shaw JA, Bartlett CA, Harvey AR, et al. (2012) Early in vivo changes in calcium ions, oxidative stress markers, and ion channel immunoreactivity following partial injury to the optic nerve. J Neurosci Res 90: 606-618.
24. Liu Y, Tang L, Chen B, (2012) Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion. Free Radic Biol Med 52: 909-915.
25. Degterev A, Yuan J, (2008) Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9: 378-390.
26. Dhanasekaran DN, Reddy EP, (2008) JNK signaling in apoptosis. Oncogene 27: 6245-6251.
27. Vander S, Levkovitch-Verbin H, (2012) Regulation of cell death and survival pathways in secondary degeneration of the optic nerve- a long-term study. Curr Eye Res 37: 740-748.
28. Cheng D, Kong H, (2011) The effect of Lycium barbarum polysaccharide on alcohol-induced oxidative stress in rats. Molecules 16: 2542-2550.
29. Cui B, Liu S, Lin X, Wang J, Li S, et al. (2011) Effects of Lycium barbarum aqueous and ethanol extracts on high-fat-diet induced oxidative stress in rat liver tissue. Molecules 16: 9116-9128.
30. Lee JJ, Hsiao CC, Yang IH, Chou MH, Wu CL, et al. (2012) High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol Vis 18: 838-850.
31. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA, (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9: 2459-2464.
32. Wetmore C, Ernfors P, Persson H, Olson L, (1990) Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol 109: 141-152.
33. Cohen-Cory S, Fraser SE, (1994) BDNF in the development of the visual system of Xenopus. Neuron 12: 747-761.
34. Gao H, Qiao X, Hefti F, Hollyfield JG, Knusel B, (1997) Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest Ophthalmol Vis Sci 38: 1840-1847.
35. Nakatani M, Shinohara Y, Takii M, Mori H, Asai N, et al. (2011) Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury. Exp Eye Res 93: 873-879.
36. Homma K, Koriyama Y, Mawatari K, Higuchi Y, Kosaka J, et al. (2007) Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury. Neurochem Int 50: 741-748.
37. Godement P, Vanselow J, Thanos S, Bonhoeffer F, (1987) A study in developing visual systems with a new method of staining neurones and their processes in fixed tissue. Development 101: 697-713.
38. Ogata-Iwao M, Inatani M, Iwao K, Takihara Y, Nakaishi-Fukuchi Y, et al. (2011) Heparan sulfate regulates intraretinal axon pathfinding by retinal ganglion cells. Invest Ophthalmol Vis Sci 52: 6671-6679.
39. Swanson KI, Schlieve CR, Lieven CJ, Levin LA, (2005) Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model. Invest Ophthalmol Vis Sci 46: 3737-3741.
40. Vidal-Sanz M, Villegas-Perez MP, Bray GM, Aguayo AJ, (1988) Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye diI. Exp Neurol 102: 92-101.
41. Hajali M, Fishman GA, Dryja TP, Sweeney MO, Lindeman M, (2009) Diagnosis in a patient with fundus albipunctatus and atypical fundus changes. Doc Ophthalmol 118: 233-238.
42. Mura M, Sereda C, Jablonski MM, MacDonald IM, Iannaccone A, (2007) Clinical and functional findings in choroideremia due to complete deletion of the CHM gene. Arch Ophthalmol 125: 1107-1113.
43. Tan MH, Mackay DS, Cowing J, Tran HV, Smith AJ, et al. (2012) Leber congenital amaurosis associated with AIPL1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy. PLoS One 7: e32330.
44. Tzekov RT, Locke KG, Hood DC, Birch DG, (2003) Cone and rod ERG phototransduction parameters in retinitis pigmentosa. Invest Ophthalmol Vis Sci 44: 3993-4000.
45. Vincent A, Wright T, Day MA, Westall CA, Heon E, (2011) A novel p.Gly603Arg mutation in CACNA1F causes Aland island eye disease and incomplete congenital stationary night blindness phenotypes in a family. Mol Vis 17: 3262-3270.